[1] |
任晓磊, 夏海波. 泌尿系结石腔镜手术后尿源性脓毒血症发生的原因及防治[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(5): 356-358.
|
[2] |
Wu H, Zhu S, Yu S, et al. Early drastic decrease in white blood count can predict uroseptic shock induced by upper urinary tract endoscopic lithotripsy: A translational study[J]. J Urol, 2015, 193(6): 2116-2122.
|
[3] |
邓刚, 马立彬, 居翔, 等. 血清降钙素原在上尿路腔内碎石术后脓毒血症诊治中的应用研究[J]. 中华医院感染学杂志, 2013, 23(24): 5924-5926.
|
[4] |
李建忠, 宁松毅, 刘广, 等. 降钙素原和内毒素联合检测对经皮肾镜碎石术尿源性脓毒血症的早期诊断价值[J]. 医学研究生学报, 2016, 29(9): 941-944.
|
[5] |
赵振华, 赵国平, 郑东升,等. 输尿管软镜碎石术后尿脓毒血症的危险因素分析[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(1): 16-19.
|
[6] |
黄洁夫, 湛海伦, 刘小彭, 等. 尿源性脓毒血症的防治[J/CD]. 中华临床医师杂志(电子版), 2012, 6(7): 164-166.
|
[7] |
Mariappan P, Smith G, Moussa SA, et al. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study[J]. BJU Int, 2006, 98(5): 1075-1079.
|
[8] |
曾国华, 李佳胜, 赵志健, 等. 逆行软性输尿管镜下钬激光碎石术治疗肾结石的有效性与安全性分析[J]. 中华泌尿外科杂志, 2015(6): 401-404.
|
[9] |
Mcaleer IM, Kaplan GW, Bradley JS, et al. Endotoxin Content in Renal Calculi[J]. J Urol, 2003, 169(5): 1813-1814.
|
[10] |
Song F, Gong B, Hao Z, et al. Risk factors of infectious complications following flexible ureteroscope with a holmium laser: a retrospective study[J]. Int J Clin Exp Med, 2015, 8(7): 11252-11259.
|
[11] |
Heyns CF. Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder[J]. World J Urol, 2012, 30(1): 77-83.
|
[12] |
杨嗣星, 郑府, 柯芹, 等. 软性输尿管镜碎石术中肾盂内压力监测方法及意义[J]. 中华泌尿外科杂志, 2014, 35(8): 575-578.
|
[13] |
Malhotra SK, Khaitan A, Goswami AK, et al. Monitoring of irrigation fluid absorption during percutaneous nephrolithotripsy: the use of 1% ethanol as a marker[J]. Anaesthesia, 2010, 56(11): 1090-1115.
|
[14] |
梁荣杰, 陈增谋, 胡春勇, 等. 输尿管软镜碎石术后尿源性脓毒血症发生的相关危险因素分析[J]. 现代医学, 2017, 45(10): 1413-1416.
|
[15] |
李锋, 左其明, 张佼, 等. 输尿管软镜碎石术后尿脓毒血症的临床调查[J]. 中国临床研究, 2018, 31(6): 775-777.
|
[16] |
罗建斌, 陈国强, 张闽杰, 等.输尿管软镜钬激光碎石术后尿源性脓毒血症60例分析及对策[J]. 中外医学研究, 2018, 16(3): 54-56.
|
[17] |
Chai FY, Nazli K, Jiffre D, et al. One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study[J]. Urology, 2011, 77(1): 45-49.
|
[18] |
Kumar S, Bag S, Ganesamoni R, et al. Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis[J]. Urol Res, 2012, 40(1): 79-86.
|
[19] |
高小峰, 张威, 彭泳涵, 等. 输尿管软镜碎石术后SIRS发生的高危因素分析[J/CD]. 泌尿外科杂志(电子版), 2014, 6(4): 5-9.
|
[20] |
葛启斌, 潘昊, 陈慧英,等. 肾穿刺造瘘预防输尿管软镜钬激光碎石术后感染的研究[J]. 中华医院感染学杂志, 2016, 26(3): 633-635
|
[21] |
余家俊, 郭永连, 李国灏, 等. 肾输尿管腔内微创术后尿源性脓毒血症患者临床治疗效果及诱发感染的相关因素分析[J]. 中华医院感染学杂志, 2016, 26(9): 2102-2104
|
[22] |
李天, 孙祥宙, 盛明, 等. 输尿管软镜负压鞘在输尿管软镜治疗感染性肾结石术中的应用[J]. 实用医学杂志, 2018, 34(1): 79-82.
|
[23] |
Zhong W, Leto G, Wang L, et al. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors[J]. J Endourology, 2015, 29(1): 25-8.
|
[24] |
Margel D, Ehrlich Y, Brown N, et al. Clinical implication of routine stone culture in percutaneous nephrolithotomy-a prospective study[J]. Urology, 2006, 67(1): 26-29.
|
[25] |
陈斌. 经皮肾镜碎石取石术后尿脓毒血症危险因素分析及防治进展[J]. 临床外科杂志, 2017, 25(2): 96-99.
|
[26] |
Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis[J]. Jama, 2013, 309(7): 678-688.
|
[27] |
Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care.[J]. N Engl J Med, 2012, 367(20): 1901-1911.
|
[28] |
Haase N Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis[J]. BMJ, 2013, 346(feb15 1): f839.
|
[29] |
罗世深. 产超广谱β-内酰胺酶大肠埃希菌的耐药特性分析[J]. 中国中医药咨讯, 2012, 4(1): 95-95.
|
[30] |
Kumar A, Roberts D, Wood K E, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Critical Care Medicine, 2006, 34(6):1589-1596.
|
[31] |
Funk D, Doucette S, Pisipati A, et al. Low-Dose Corticosteroid Treatment in Septic Shock: A Propensity-Matching Study[J]. Critical Care Medicine, 2014, 42(11): 2333-2341.
|
[32] |
姜琳瑞, 王小燕, 张群, 等. 脐带间充质干细胞对脓毒症小鼠的器官保护作用及其机制[J]. 解放军医学杂志, 2018, 43(10): 860-865.
|
[33] |
邱合信, 顾磊, 郑鲲鹏. 连续血液净化与乌司他丁联合治疗对重症脓毒血症患者IL-6、TNF-α的影响[J]. 社区医学杂志, 2017(12): 55-56.
|